These results also suggest that monoclonal antibodies against EGFR might be a novel therapeutic option in the treatment of post-angioplasty restenosis and vessel wall thickening after vascular manipulation
These results also suggest that monoclonal antibodies against EGFR might be a novel therapeutic option in the treatment of post-angioplasty restenosis and vessel wall thickening after vascular manipulation. Acknowledgments This work was supported by British Heart Foundation. function of the EGFR on rabbit monocytes was also investigated ICR62 inhibited macrophage and clean muscle mass cell…